CD274 and cancer: Most of the identified pathways were common between both comparisons, with a total of 72 identical pathways activated in both comparisons, while three pathways (‘Antioxidant Action of Vitamin C’, ‘Inhibition of Matrix Metalloproteases’ and ‘PD-1, PD-L1 cancer immunotherapy pathway’) were inhibited in both comparisons.